These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. [The common problems and available solutions of design of clinical research]. Wang X; Lin G; Zhang J Zhonghua Nei Ke Za Zhi; 2014 Apr; 53(4):262-4. PubMed ID: 24857296 [No Abstract] [Full Text] [Related]
52. Who are these "nonsmokers"? Hughes JR Am J Public Health; 1996 May; 86(5):745-6. PubMed ID: 8629733 [No Abstract] [Full Text] [Related]
54. Pharmacologic reperfusion therapy for acute myocardial infarction. Lowe HC; Neill BD; Van de Werf F; Jang IK J Thromb Thrombolysis; 2002 Dec; 14(3):179-96. PubMed ID: 12913398 [TBL] [Abstract][Full Text] [Related]
55. Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction. Vetrano A; Carotenuto R; Corsini F; Schioppa M; Martone A; Melorio S; Sideri F; Romano S; Chieffo C; Corsini G Am J Cardiol; 2004 Apr; 93(7):914-6. PubMed ID: 15050497 [TBL] [Abstract][Full Text] [Related]
56. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V. Ferreira D Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168 [No Abstract] [Full Text] [Related]
57. Thrombolytic therapy: new dimensions 2009. Guha S; Mukherjee S; Hema MB Indian Heart J; 2009; 61(5):415-21. PubMed ID: 20635755 [No Abstract] [Full Text] [Related]
58. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI. Otterstad JE; Brosstad F Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241 [No Abstract] [Full Text] [Related]
59. ASSENT-3: implications for future trial design and clinical practice. Van de Werf F Eur Heart J; 2002 Jun; 23(12):911-2. PubMed ID: 12069439 [No Abstract] [Full Text] [Related]